Marinus Investor Advances Suit Over Statements About Drug Study

A Marinus Pharmaceuticals Inc. investor convinced a federal judge to let stand allegations the drug company knew but failed to disclose it would end a third-phase study of an intravenous seizure disorder drug due to financial problems.

The investor leading the case adequately alleged Marinus’ former executives misleadingly touted its commitment to its so-called RAISE study, Judge John R. Padova said Wednesday. They also misrepresented the probability for positive results of an interim analysis when the trial was secretly marred by data management and integrity issues, he said.

An ex-employee testified to the investor’s counsel that the executives recommended skipping ...